Karin A H Kaasjager Selected Research

Critical Care (Surgical Intensive Care)

11/2021

Code status documentation at admission in COVID-19 patients: a descriptive cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin A H Kaasjager Research Topics

Disease

4	COVID-19 01/2024 - 01/2021
3	Kidney Diseases (Kidney Disease) 01/2023 - 11/2010
3	Hemorrhage 01/2020 - 03/2002
2	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 01/2021
2	Inappropriate ADH Syndrome (SIADH) 01/2021 - 01/2021
2	Pulmonary Embolism 07/2019 - 01/2017
2	Proteinuria 02/2014 - 09/2012
1	Hypertension (High Blood Pressure) 01/2023
1	Sepsis (Septicemia) 05/2022
1	Chronic Renal Insufficiency 02/2022
1	Infections 01/2022
1	Hyponatremia 01/2021
1	Neoplasms (Cancer) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Thrombophilia 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Venous Thromboembolism 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2014
1	Weight Loss (Weight Reduction) 09/2012
1	Anemia 09/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2010
1	Diabetes Mellitus 11/2010

Drug/Important Bio-Agent (IBA)

3	CreatinineIBA 01/2023 - 02/2014
3	SodiumIBA 01/2021 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2022
2	Vitamin D FDA LinkGeneric 02/2014 - 09/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014 - 09/2012
2	LDL CholesterolIBA 02/2014 - 09/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 09/2012
1	Oxygen (Dioxygen)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	LithostathineIBA 05/2022
1	thrombin receptor peptide (42-47)IBA 01/2021
1	IpilimumabIBA 01/2021
1	Crystalloid SolutionsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	DiureticsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Vasopressins (Vasopressin)IBA 01/2021
1	P-SelectinIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	CI 22IBA 07/2019
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 02/2014
1	Factor VII (Proconvertin)IBA 03/2002

Therapy/Procedure

2	Therapeutics 01/2024 - 01/2021
2	Fluid Therapy (Oral Rehydration Therapy) 01/2021 - 01/2021
1	Length of Stay 02/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2022
1	Critical Care (Surgical Intensive Care) 11/2021
1	Urinary Catheters 01/2021
1	Catheters 07/2019
1	Contraindications 07/2019
1	Glycemic Control 09/2012
1	Kidney Transplantation 11/2010